Discover Daily by Perplexity

First Schizophrenia Med in 30 Years, New Cell Type Discovered, and The Nine Planetary Boundaries

4 snips
Sep 30, 2024
Exciting advancements in medicine are on the horizon! The FDA has approved Cobenfy, the first new schizophrenia medication in over 30 years, targeting cholinergic receptors for better treatment. A groundbreaking discovery of EndoMac progenitor cells in mice reveals their potential to enhance wound healing. Meanwhile, critical environmental boundaries are under threat, with six out of nine already crossed, highlighting urgent issues around climate change and biodiversity loss. The interconnectedness of these challenges calls for immediate action!
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Cobenfy's Novel Approach

  • The FDA approved Cobenfy, a new schizophrenia drug targeting cholinergic receptors.
  • This differs from existing antipsychotics, which target dopamine receptors.
INSIGHT

EndoMac Progenitors

  • EndoMac progenitors, discovered in mice, can transform into blood vessel and immune cells.
  • This could revolutionize tissue repair, especially for conditions like diabetes.
INSIGHT

Planetary Boundaries Crossed

  • Humanity has crossed six of nine planetary boundaries, including climate change and biodiversity loss.
  • This risks irreversible environmental damage and threatens human civilization.
Get the Snipd Podcast app to discover more snips from this episode
Get the app